Do Soon Kim is a BD & Product at Inceptive, where they work on bringing Biological Software to the world, with a focus on RNA medicines. Prior to Inceptive, they worked as a Research Engineer at Eli Lilly and Company, a Visiting Research Scientist at Stanford University, and a Graduate Researcher at Northwestern University. Their background includes experiences in various research and engineering roles, showcasing their expertise in synthetic biology, mRNA vaccine design, and democratized medicines.
September, 2021 - present